Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Slaton

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The Journal of Urology|January 1, 1996
Proximal ureteral stent migration: an avoidable complication?J W Slaton, K A Kropp
The Journal of Urology|August 1, 1994
Conservative management of suspected bladder rupture after augmentation enterocystoplastyJ W Slaton, K A Kropp
Transplantation|March 27, 1996
Case report--sirolimus rescue therapy for refractory renal allograft rejectionJ W Slaton, B D Kahan
HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery|January 1, 1993
Massive necrotizing pancreatitis in an immunosuppressed renal transplant recipient (successful therapy)J W Slaton, J M Howard, S H Selman
The Journal of Urology|November 1, 1994
Exposure to alkyllysophospholipids inhibits in vitro invasion of transitional cell carcinomaJ W Slaton, J A Hampton, S H Selman
Urology|May 19, 2001
P53 in bladder cancer: mechanism of action, prognostic value, and target for therapyJ W Slaton, W F Benedict, C P Dinney
Current Cancer Drug Targets|February 18, 2004
Protein kinase CK2 as regulator of cell survival: implications for cancer therapyG M Unger, A T Davis, J W Slaton, et al.
The Journal of Urology|March 1, 1994
Cyclosporine versus azathioprine: a 5-year followup of 200 consecutive cadaver renal transplant recipientsJ W Slaton, K A Kropp, J S Jhunjhunwala, et al.
The Journal of Urology|October 19, 1999
Early nasogastric tube removal combined with metoclopramide after radical cystectomy and urinary diversionS M Donat, J W Slaton, L L Pisters, et al.
The Journal of Urology|August 24, 1999
A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladderJ W Slaton, D A Swanson, H B Grossman, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Journal of Urology|January 1, 1996
Proximal ureteral stent migration: an avoidable complication?J W Slaton, K A Kropp
The Journal of Urology|August 1, 1994
Conservative management of suspected bladder rupture after augmentation enterocystoplastyJ W Slaton, K A Kropp
Transplantation|March 27, 1996
Case report--sirolimus rescue therapy for refractory renal allograft rejectionJ W Slaton, B D Kahan
HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery|January 1, 1993
Massive necrotizing pancreatitis in an immunosuppressed renal transplant recipient (successful therapy)J W Slaton, J M Howard, S H Selman
The Journal of Urology|November 1, 1994
Exposure to alkyllysophospholipids inhibits in vitro invasion of transitional cell carcinomaJ W Slaton, J A Hampton, S H Selman
Urology|May 19, 2001
P53 in bladder cancer: mechanism of action, prognostic value, and target for therapyJ W Slaton, W F Benedict, C P Dinney
Current Cancer Drug Targets|February 18, 2004
Protein kinase CK2 as regulator of cell survival: implications for cancer therapyG M Unger, A T Davis, J W Slaton, et al.
The Journal of Urology|March 1, 1994
Cyclosporine versus azathioprine: a 5-year followup of 200 consecutive cadaver renal transplant recipientsJ W Slaton, K A Kropp, J S Jhunjhunwala, et al.
The Journal of Urology|October 19, 1999
Early nasogastric tube removal combined with metoclopramide after radical cystectomy and urinary diversionS M Donat, J W Slaton, L L Pisters, et al.
The Journal of Urology|August 24, 1999
A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladderJ W Slaton, D A Swanson, H B Grossman, et al.
Pageof 3